2021-11-16-世界卫生组织-Cervical_cancer_Antigua_and_Barbuda_2021_country_profile_1页_64kb

报告摘要

Crude cervical cancer incidence per 100,000 women (2020): Data not available (ND).
Age-standardized cervical cancer incidence per 100,000 women (2020): ND.
Cumulative risk of cervical cancer ages 0-74 (2020): ND.
Cervical cancer deaths (2019): 310.
Mortality-to-incidence ratio (2020): ND.
Population-based cancer registry exists (2021): Yes.

HPV vaccination programme exists (2020): Yes.
HPV included in national vaccination programme: Yes.
Scale of vaccination programme: ND.
Year of introduction: ND (likely around 9-13 years based on target).
Primary target cohort: 9-13 years (girls).
Vaccination programme coverage among girls (2020): ND.
Related risk factors: Tobacco use prevalence (2020): ND; Condom use at last high-risk sex: ND; HIV incidence (2019) per 1000: ND.
Programme coverage (2018): National target population (9-14-year-old girls) vaccination rate by age 15: ND.

National screening programme for cervical cancer exists (2021): Yes (target age 21-65 years).
Primary screening test used (2021): Cytology.
Programme/guidelines for early detection exist (2021): Yes.
Clearly defined referral system from primary to secondary/tertiary care: Yes.
Ever screened in last 5 years: 72% of women (2019).
Percentage of women (ages 30-49) screened: 84%.

National guidelines on cervical cancer management exist (2021): Yes.
Cancer diagnosis and treatment services generally available (2021).
Number of radiotherapy and brachytherapy units per 10,000 cancer patients: ND.
Radiation oncologists, medical physicists, radiologists, nuclear medicine physicians: Data not available (ND).
Cancer centre or department at tertiary level: No data available.
Palliative care for patients with non-communicable diseases: Generally available in public health system.
Reported annual opioid consumption (2017): Data not available, excluding methadone.